Under the terms of the deal, the company will gain the exclusive global license to develop, manufacture, and commercialize Chinese drugmaker Hansoh Pharmaceutical Group Co.s HS-10535, an experimental oral drug that targets the receptors for GLP-1, Merck said in a statement Wednesday
Whether the combination carries safety risks that neither component carries alone
Brescia C, Audia S, Pugliano A, Scaglione F, Iuliano R, Trapasso F, et al
If Qsymia is unaffordable, other FDA-approved prescription or over-the-counter weight loss medications combined with healthy eating, exercise, and lifestyle changes can also support sustainable weight loss goals